Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions

: Regulated Authorization - Herceptin (trastazumab) 150 mg for Intravenous Use - XML Representation

Raw xml | Download


<RegulatedAuthorization xmlns="http://hl7.org/fhir">
  <id value="authherceptin150"/>
  <meta>
    <profile
             value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization authherceptin150</b></p><a name="authherceptin150"> </a><a name="hcauthherceptin150"> </a><a name="authherceptin150-en-US"> </a><p><b>identifier</b>: <code>https://pmda-approvalandlicenseno/</code>/21300AMY00128 (use: official, )</p><p><b>subject</b>: <a href="MedicinalProductDefinition-medprodherceptin150.html">MedicinalProductDefinition: identifier = http://iyaku.info/medicine#4291447D2024; type = Medicinal Product; domain = Human use; status = active; legalStatusOfSupply = Medicinal product subject to medical prescription</a></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/rmswi/ /#100000072062}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{urn:iso:std:iso:3166 JP}">Japan</span></p><p><b>status</b>: <span title="Codes:{http://hl7.org/fhir/publication-status active}">Active</span></p><p><b>statusDate</b>: 2002-08-01 13:28:17+0000</p><p><b>holder</b>: <a href="Organization-orgchugai.html">Organization Chugai Pharmaceutical Co., Ltd.</a></p></div>
  </text>
  <identifier>
    <use value="official"/>
    <system value="https://pmda-approvalandlicenseno/"/>
    <value value="21300AMY00128"/>
  </identifier>
  <subject>🔗 
    <reference value="MedicinalProductDefinition/medprodherceptin150"/>
  </subject>
  <type>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi/"/>
      <code value="/#100000072062"/>
    </coding>
    <text value="Marketing Authorisation"/>
  </type>
  <region>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="JP"/>
    </coding>
    <text value="Japan"/>
  </region>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
    </coding>
    <text value="Active"/>
  </status>
  <statusDate value="2002-08-01T13:28:17Z"/>
  <holder>🔗 
    <reference value="Organization/orgchugai"/>
  </holder>
</RegulatedAuthorization>